Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study (Q43259606)

17 November 2017

Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study (English)

1 reference

lymphoproliferative disorders

17 November 2017

0 references

1 reference

13

1 reference

17 November 2017

15

1 reference

17 November 2017

Tabassome Simon

11

0 references

Antoine Cortot

object named as

Antoine Cortot

8

0 references

Jean-Frédéric Colombel

4

object named as

Jean Frédéric Colombel

1 reference

17 November 2017

1

Laurent Beaugerie

1 reference

17 November 2017

12

Marc Maynadié

1 reference

17 November 2017

2

Nicole Brousse

1 reference

17 November 2017

16

CESAME Study Group

1 reference

17 November 2017

6

Jacques Cosnes

1 reference

17 November 2017

3

Anne Marie Bouvier

1 reference

17 November 2017

Marc Lémann

5

1 reference

17 November 2017

Xavier Hébuterne

7

1 reference

17 November 2017

Yoram Bouhnik

9

1 reference

17 November 2017

Jean Pierre Gendre

10

1 reference

17 November 2017

Jean Faivre

14

1 reference

17 November 2017

language of work or name

English

0 references

publication date

1 November 2009

1 reference

17 November 2017

1 reference

17 November 2017

374

1 reference

17 November 2017

9701

1 reference

17 November 2017

1617-1625

1 reference

Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis

17 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961302-7

7 January 2021

American Gastroenterological Association Institute medical position statement on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961302-7

7 January 2021

Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961302-7

7 January 2021

Inflammatory bowel disease is not associated with an increased risk of lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961302-7

7 January 2021

Risk of haematopoietic cancer in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961302-7

7 January 2021

Epstein-Barr virus-positive lymphoma in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961302-7

7 January 2021

Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961302-7

7 January 2021

Meta-analysis of risk of malignancy with immunosuppressive drugs in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961302-7

7 January 2021

A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961302-7

7 January 2021

Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961302-7

7 January 2021

Infliximab for induction and maintenance therapy for ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961302-7

7 January 2021

Effects of light smoking consumption on the clinical course of Crohnʼs disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961302-7

7 January 2021

Effects of mid-point imputation on the analysis of doubly censored data

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961302-7

7 January 2021

Lymphomas after solid organ transplantation: a collaborative transplant study report

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961302-7

7 January 2021

Post-transplant lymphoproliferative disorders occurring after renal transplantation in adults: report of 230 cases from the French Registry.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961302-7

7 January 2021

Relaxing the rule of ten events per variable in logistic and Cox regression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961302-7

7 January 2021

Model-checking techniques based on cumulative residuals

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961302-7

7 January 2021

Lymphoma risk in inflammatory bowel disease: is it the disease or its treatment?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961302-7

7 January 2021

Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961302-7

7 January 2021

Healing of severe recurrent ileitis with azathioprine therapy in patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961302-7

7 January 2021

Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961302-7

7 January 2021

Immunosuppressive agents in solid organ transplantation: Mechanisms of action and therapeutic efficacy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961302-7

7 January 2021

Epstein-Barr virus-associated lymphoproliferative disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961302-7

7 January 2021

The SAP and SLAM families in immune responses and X-linked lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961302-7

7 January 2021

Fatal infectious mononucleosis: a severe complication in the treatment of Crohn's disease with azathioprine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961302-7

7 January 2021

Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961302-7

7 January 2021

Cell origin of pyothorax-associated lymphoma: a lymphoma strongly associated with Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961302-7

7 January 2021

Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961302-7

7 January 2021

Azathioprine for maintenance of remission in Crohn's disease: benefits outweigh the risk of lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961302-7

7 January 2021

10.1016/S0140-6736(09)61302-7

Identifiers

DOI

1 reference

release_k3xkajk5uvge7o7fd7mr6knenq

17 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/k3xkajk5uvge7o7fd7mr6knenq

24 November 2022

mapped directly with Wikidata item

1 reference